Cargando…
Severe Diarrhea in the Setting of Immune Checkpoint Inhibitors
Immune checkpoint inhibitors (ICPIs) are novel therapeutic agents targeting a variety of cancers by enhanced T cell activation. Immune-related adverse events (irAEs) commonly occur with ICPI use and can affect multiple organ systems including the gastrointestinal tract. Due to irAEs, the use of ICPI...
Autores principales: | Kuo, Jean R., Davis, Amy D., Rodriguez, Eduardo A., Vela, Marcelo F., Heigh, Russell I., Salomao, Marcela A., Gurudu, Suryakanth R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323374/ https://www.ncbi.nlm.nih.gov/pubmed/30631256 http://dx.doi.org/10.1159/000493183 |
Ejemplares similares
-
Comparison of morning versus afternoon cecal intubation rates
por: Wells, Christopher D, et al.
Publicado: (2007) -
Coexisting Crohn's Disease and Takayasu's Arteritis in Two Patients Treated with Anti-TNF-α Therapies
por: Ratuapli, S., et al.
Publicado: (2010) -
The efficacy of immune checkpoint inhibitors in thoracic malignancies
por: Remon, Jordi, et al.
Publicado: (2021) -
Breast Cancer Metastasis Presenting as Colonic Polyps
por: Bering, Jamie, et al.
Publicado: (2020) -
Multifocal Carcinoid Tumor of Small Intestine: A Rare Cause of Chronic Obscure Gastrointestinal Bleeding, Suspected on Capsule Endoscopy and Diagnosed on Double Balloon Enteroscopy
por: Hernandez, Jose C., et al.
Publicado: (2011)